Nanosonics: A clean story
Morgans
Although the FY15 results were slightly behind our forecasts, the result had been well flagged to the market. With a direct sales force in the US now fully established we expect to see a substantially stronger FY16. A growing global need/requirement for high level disinfection will support long term growth. A key short term catalyst expected 1H16 will be a set of guidelines published in Scotland and England recommending the use of automated validated decontamination systems, similar to the guidelines released in Wales. (NAN, ADD, Price Target A$1.99) Report attached, here is the link to the blog site: (VIEW LINK)
1 topic
1 stock mentioned
Senior Analyst at Morgans covering healthcare, life science, telecommunications, technology and media. I've spent the last twenty years investing in and researching emerging companies and have developed a wide network of contacts across these...
Expertise
No areas of expertise
Senior Analyst at Morgans covering healthcare, life science, telecommunications, technology and media. I've spent the last twenty years investing in and researching emerging companies and have developed a wide network of contacts across these...
Expertise
No areas of expertise